About Us

Prostate cancer

Urothelial cancer

Epidemiology

Functional Urology

Andrology

Pediatric urology

People

Research Objectives

We investigate clinical, epidemiological, pathological, molecular and genetic characteristics of urological diseases. Our goal is to improve urological healthcare, from the general practitioner to tertiary academic care.

Collaborations

The Department of Urology of the Erasmus University Medical Center, Rotterdam, is embedded in the dynamic, internationally competitive research community of  several clinical, translational and basic research groups. Our focus lies in Protate Cancer, Urothelial Cancer, Functional Urology, Andrology and Pediatric Urology. We have longstandig collaborations with multiple other acadamic centers, both internationally and at a national level, and host fruitful relationships with our industry partners. Our department is renowed for participation at the highest level to improve European Patient Guidelines.

Academic Excellence

Our motto: “research” = care. We aim to improve the diagnosis, treatment and outcome in patients with urologic diseases by translational, clinical and epidemiological research, and education of students and professionals. Providing excellent academic care at a tertiary level is in our DNA. Do you want to be part of our team, either as as aspiring researcher or student, don’t hesitate to send your contact information to one of our Principal Investigators.

The Department of Urology is residing in the Staff Tower (Na building, 15th floor), the Erasmus MC Cancer Institute (Nt building, 2nd floor) and in the Josephine Nefkens Institute (Be-building, 3rd floor).

The Department Chair is Prof. Dr. Joost L. Boormans.

Latest news

New publication: A 2-year prospective evaluation of the Prostate Health Index in guiding biopsy decisions in a large cohort

Peter Ka-Fung Chiu, Alex Qinyang Liu, Sui-Yan Lau, Jeremy Yuen-Chun Teoh, Chi-Chun Ho, Chi-Hang Yee, See-Ming Hou, Chi-Kwok Chan, Wai-Lun...
Read More

New publication: Selecting the right treatment: Health outcome priorities in older patients with bladder cancer

Vera C Rutten , Cornelia M Al , Suzanne Festen , Tahlita C M Zuiverloon , Joost L Boormans ,...
Read More

New publication: Risk calculators for the detection of prostate cancer: a systematic review

Frederique B Denijs, Meike J van Harten, Jonas J L Meenderink, Renée C A Leenen, Sebastiaan Remmers, Lionne D F...
Read More

New publication: Novel Delivery Systems and Pharmacotherapeutic Approaches for the Treatment of Non–muscle-invasive Bladder Cancer

Authors: Félix Guerrero-Ramos, Joost L. Boormans, Siamak Daneshmand, Paolo Gontero, Ashish M. Kamat, Morgan Rouprêt, Antoni Vilaseca, Shahrokh F. Shariat...
Read More

New event: Inaugural lecture prof.dr. B.F.M. Blok, Erasmus MC

The rector magnificus of the Erasmus University Rotterdam announces that at Erasmus MC - Faculty of Erasmus University Rotterdam Dr....
Read More

New publication: Prognostic Factor Risk Groups for Clinical Stage I Seminoma: An Individual Patient Data Analysis by the European Association of Urology Testicular Cancer Guidelines Panel and Guidelines Office

Joost L Boormans 1, Richard Sylvester 2, Lynn Anson-Cartwright 3, Rachel M Glicksman 4, Robert J Hamilton 3, Ezra Hahn...
Read More

New publication: NPEPPS Is a Druggable Driver of Platinum Resistance

Robert T Jones # 1, Mathijs Scholtes # 2, Andrew Goodspeed # 1 3, Maryam Akbarzadeh 2 4, Saswat Mohapatra...
Read More

New publication: Summary of the 2024 Update of the European Association of Urology Guidelines on Neurourology

Andrea M Sartori 1, Thomas M Kessler 2, David M Castro-Díaz 3, Peter de Keijzer 4, Giulio Del Popolo 5, Hazel Ecclestone 6, Dennis Frings 7, Jan Groen 7, Rizwan Hamid 8, Gilles Karsenty 9, Stefania Musco 5, Bárbara Padilla-Fernández 3, Jürgen Pannek 10, Natasha Schouten 4, Angela...
Read More

New publication: Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial

Prof Andrea Necchi MD a, Mathieu Roumiguié MD b, Prof Ashish M Kamat MD c, Neal D Shore MD d, Prof Joost L Boormans MD PhD e, Prof Ahmet Adil Esen MD f, Prof Thierry Lebret MD PhD g, Shuya Kandori MD h, Prof Dean F Bajorin MD j, Laurence E M Krieger MD k, Scot A Niglio MD l, Prof Edward M Uchio MD m, Ho Kyung Seo MD PhD n, Prof Ronald de Wit MD PhD e, Prof Eric A Singer MD o p, Petros Grivas MD PhD q, Prof Hiroyuki Nishiyama MD i, Haojie Li MD r, Pranshu Baranwal MSc r, Margot Van den Sigtenhorst-Fijlstra MD...
Read More

New publication: Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1-S Transition.

Buck SAJ, Van Hemelryk A, de Ridder C, Stuurman D, Erkens-Schulze S, van 't Geloof S, Teubel WJ, Koolen SLW,...
Read More

New publication: The effect of botulinum toxin A in children with non-neurogenic therapy-refractory dysfunctional voiding – A systematic review.

Hoelscher SAA, de Angst IB, Buijnsters ZA, Bramer WM, Akkermans FW, Kuindersma ME, Scheepe JR, Hoen LA'. Link to article:...
Read More

New publication: Disease progression in Bacillus Calmètte Guerin unresponsive non-muscle invasive bladder cancer patients with carcinoma in situ, participating in clinical trials on bladder-sparing treatment.

Olga M Pijpers 1, Joost L Boormans 1 Link to article: https://pubmed.ncbi.nlm.nih.gov/38590961/  
Read More

New publication: Whole-genome mapping of APOBEC mutagenesis in metastatic urothelial carcinoma identifies driver hotspot mutations and a novel mutational signature.

J Alberto Nakauma-González 1, Maud Rijnders 2, Minouk T W Noordsij 3, John W M Martens 2, Astrid A M van der Veldt 4, Martijn P J Lolkema 2, Joost L Boormans 5, Harmen...
Read More

New publication: Darolutamide does not interfere with OATP-mediated uptake of docetaxel

Stefan A J Buck, Zahra Talebi, Thomas Drabison, Yan Jin, Alice A Gibson, Peng Hu  Peter de Bruijn  Corrina M A de Ridder, Debra Stuurman, Shuiying Hu, Wytske...
Read More

New publication: The Diagnostic Accuracy of Cystoscopy for Detecting Bladder Cancer in Adults Presenting with Haematuria: A Systematic Review from the European Association of Urology Guidelines Office

Wout Devlies,  Joep J de Jong, Fabian Hofmann, Harman Max Bruins, Tahlita C M Zuiverloon, Emma Jane Smith, Yuhong Yuan, Bas W G van Rhijn, Hugh Mostafid, Nancy...
Read More

New publication: Alignment of molecular subtypes across multiple bladder cancer subtyping classifiers

Moritz J Reike, Joep J de Jong, Tarek A Bismar, Stephen A Boorjian, Omar Y Mian, Jonathan L Wright  Marc A Dall'Era, Hristros Z Kaimakliotis, Yair Lotan, Joost...
Read More

New publication: A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy

Florus C de Jong , Iris G Iflé, Angelique C van der Made, Denise Kooper, Joep J de Jong , Martine Franckena, Tahlita C M Zuiverloon,  Wim van Criekinge, Luca...
Read More

New publication: Evolution of European prostate cancer screening protocols and summary of ongoing trials

Meike J van Harten 1, Monique J Roobol 2, Pim J van Leeuwen 3, Peter-Paul M Willemse 1, Roderick C N van den Bergh 2 4 Abstract Population-based organised repeated...
Read More

New publication: Short-term Changes in Health-related Quality of Life of Patients Undergoing Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: Results from a Prospective Phase 2 Clinical Trial

Thomas van Doeveren 1, Sebastiaan Remmers 1, Vera Atema 2, Roderick C N van den Bergh 3, Egbert R Boevé 4, Erik B Cornel 5, Antoine G van der Heijden 6, Kees Hendricksen 7, Evelyne C...
Read More

New publication: Performance of magnetic resonance imaging-based prostate cancer risk calculators and decision strategies in two large European medical centres

Petter Davik 1 2, Sebastiaan Remmers 3, Mattijs Elschot 4 5, Monique J Roobol 3, Tone Frost Bathen 2 4, Helena Bertilsson 1 2 Abstract   Objectives: To compare the performance of currently available biopsy decision...
Read More

 

The full archive can be found by clicking here